RIP15, identified as a pivotal protein within the cellular regulatory network, plays a significant role in the intricate balance of metabolic pathways. This protein is critical in the modulation of gene expression, particularly in the context of lipid and cholesterol homeostasis. The expression of RIP15 is not static but is subject to dynamic changes in response to a myriad of molecular signals within the cell. Research has elucidated that various endogenous and synthetic ligands can influence the activity and expression levels of RIP15. For example, naturally occurring oxysterols, such as 22(R)-Hydroxycholesterol and 24(S)-Hydroxycholesterol, are known to bind to RIP15, functioning as ligands that can elicit a cascade of regulatory mechanisms aimed at maintaining cellular lipid equilibrium. These oxysterols are crucial as they are found in cholesterol itself and reflect the cell's current state of cholesterol balance, providing a feedback mechanism that can induce the expression of RIP15, thereby tailoring the cell's response to its internal and external environment.
On the synthetic side, compounds such as T0901317 and GW3965 have been identified to have a high affinity for RIP15, acting as potent agonists that can substantially enhance the expression of this protein. These compounds, through their targeted interaction with RIP15, can initiate a robust transcriptional response. Moreover, other molecules like Geranylgeraniol and Beta-sitosterol, although not directly interacting with RIP15, contribute to the pool of precursors and mimetics that can influence the cellular lipid milieu. Such compounds can indirectly lead to an upregulation of RIP15 expression, as the protein responds to changes in cellular lipid levels and metabolism. Importantly, the activity of RIP15 and its expression induced by these compounds are of interest in the broader context of cellular regulation, where maintaining a balance of lipids is essential for various cellular functions. Understanding the molecular dynamics of RIP15 expression and regulation provides a window into the cell's ability to adapt to a fluctuating metabolic landscape, ensuring its survival and proper functioning.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
T 0901317 | 293754-55-9 | sc-202824 sc-202824A | 10 mg 50 mg | $89.00 $224.00 | 5 | |
T 0901317 is known to bind directly to RIP15, acting as an agonist to significantly enhance its transcriptional activity, leading to an upregulation of its expression and an induction of its target genes involved in lipid metabolism. | ||||||
GW3965 | 405911-09-3 | sc-490151 sc-490151A sc-490151B | 10 mg 50 mg 1 g | $260.00 $872.00 $1637.00 | ||
GW3965 is a synthetic ligand that targets RIP15, stimulating its transcriptional activity, which in turn can lead to an increased expression of genes under RIP15's regulatory domain, influencing lipid homeostasis. | ||||||
22(R)-hydroxycholesterol | 17954-98-2 | sc-205106 sc-205106A sc-205106B | 1 mg 5 mg 10 mg | $110.00 $357.00 $612.00 | 1 | |
This oxysterol is an endogenous ligand for RIP15, capable of stimulating its activity and thereby promoting an increase in RIP15 expression, which is crucial for the regulation of cholesterol metabolism. | ||||||
9-cis-Retinoic acid | 5300-03-8 | sc-205589 sc-205589B sc-205589C sc-205589D sc-205589A | 1 mg 25 mg 250 mg 500 mg 5 mg | $71.00 $424.00 $3121.00 $5722.00 $148.00 | 10 | |
9-cis-Retinoic Acid activates RXR, the heterodimeric partner of RIP15, which can stimulate RIP15's transcriptional activity and subsequently increase its expression levels within the cell nucleus. | ||||||
β-Sitosterol | 83-46-5 | sc-204432 sc-204432A | 10 g 25 g | $61.00 $217.00 | 5 | |
β-Sitosterol can engage RIP15 as a cholesterol-like ligand, inducing its transcriptional activity, which may result in an upsurge of RIP15-mediated regulation of gene expression. | ||||||
Geranylgeraniol | 24034-73-9 | sc-200858 sc-200858A | 20 mg 100 mg | $162.00 $474.00 | 14 | |
Geranylgeraniol may indirectly stimulate RIP15 expression by contributing to the pool of intermediates in the mevalonate pathway, which can modulate cellular cholesterol levels and receptor activity. | ||||||
25-Hydroxycholesterol | 2140-46-7 | sc-214091B sc-214091 sc-214091A sc-214091C | 5 mg 10 mg 25 mg 100 mg | $53.00 $91.00 $169.00 $474.00 | 8 | |
Acting as an LXRβ agonist, 25-Hydroxycholesterol has the potential to initiate and enhance the transcriptional activity of RIP15, increasing its expression and impacting cholesterol regulatory mechanisms. | ||||||
DHEA | 53-43-0 | sc-202573 | 10 g | $111.00 | 3 | |
DHEA might stimulate RIP15 expression by serving as a substrate for hormone synthesis, which can then activate nuclear receptors, including those that interact with RIP15. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
By activating PPAR-gamma, Pioglitazone has the potential to upregulate the expression of genes that are also responsive to RIP15, potentially leading to a synergistic stimulation of RIP15 expression. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Simvastatin can induce a compensatory upregulation of RIP15 expression by inhibiting cholesterol biosynthesis, which may trigger a feedback response to maintain lipid balance. | ||||||